Skip to content

IPHA - Innate Pharma SA - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchI

Innate Pharma

IPHA · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

I

IPHAInnate Pharma

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $2.71
52-wk low: $1.17
Prev close: $2.01
Mkt cap: $199.1M
Beta: 0.86
P/S: 22.1x

Smart money

2 funds hold a position.

Real smart money

Funds holding this stock

2 holders

Combined position$36K

CI
Citadel
Ken Griffin · Q2 2026 13F
$23K
position
MI
Millennium
Israel Englander · Q1 2026 13F

Earnings

Earnings

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $199M

Valuation

P/S22.11
P/B20.10

Quality

Operating margin-690.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: IPHA
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $199.07M
Beta: 0.86

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

20.1x

Profit margin

+0.0%

Op margin

-690.0%

ROE

-271.4%

$13K

position

Coverage gaps for IPHA

No recent insider trade
No recent Congress trade
No recent market-voice mention

No earnings history on record for this stock yet.

The next reported quarter will appear here

Next report

What the street expects next

-271.4%

ROA-38.9%

Growth

Beta0.86